Omar H. Khalil

Omar H. Khalil is an accomplished executive with extensive experience in the biomedical and healthcare sectors. Currently serving as Managing Director and Partner at SANTÉ since 2020, Khalil also holds various board positions across multiple companies, including MycRx, Kestrel Therapeutics, Solu Therapeutics, Geneos Therapeutics, and a board observer role at Sensorium Therapeutics. Prior to these roles, Khalil was Vice President and General Manager at kaleo from 2017 to 2020 and held several key positions at Baxter International Inc. from 2011 to 2017. Khalil began the career at McKinsey & Co. as a Business Analyst and has a strong educational background with a Master’s and Bachelor’s degree in Biomedical Engineering from the University of Michigan.